Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1174
| Despition | Synthetic nanodiscs offer a stable and biologically relevant environment that closely mimics cell membranes and enables full-length transmembrane human GD97 protein to be purified and analysed in vitro. |
| SIZE | 10 µg |
| Source | Synthetic |
| Protein Length | Full length protein. |
| Expression System | HEK293 cells |
| Protein Species | Human |
| Molecular Weight | 87.1 kDa |
| Form | Lyophilized |
| Storage | Lyophilized was stored at -20°C to -80°C, while reconstituted was aliquot and stored at -80°C. Avoid freeze/thaw cycles. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1627 | Human Visfatin Protein, His (AC1627) | 5 µg | inquiry |
| ACPP-1300 | GTP cyclohydrolase 1 Blocking Peptide (AC1300) | 250 µg | inquiry |
| ACPP-1163 | Recombinant Human GFAP Protein (Fc Tag) (AC1163) | 50 µg | inquiry |
| ACPP-1759 | Rat CDNF Protein (AC1759) | 5 µg | inquiry |
| ACPP-1187 | 5HT1A Blocking Peptide (AC1187) | 250 µg | inquiry |
| ACPP-1385 | Human TGFBI Protein (AC1385) | 5 µg | inquiry |
| ACPP-1150 | Synthetic Nanodisc Human TRPV1 Protein (AC1150) | 10 µg | inquiry |
| ACPP-1475 | Human MT3 Protein (AC1475) | 2 µg | inquiry |
| ACPP-1706 | Human HPCAL1 Protein (AC1706) | 2 µg | inquiry |
| ACPP-1528 | Human RCAN3 Protein (AC1528) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.